Table 2.
The surgical outcomes of the patients
| Total n = 34 (%) |
Open partial gastrectomy n = 22 (%) |
Laparoscopic partial gastrectomy n = 12 (%) |
p | |
|---|---|---|---|---|
| Tumor site | 0.754 | |||
| Cardia | 9 (26.5%) | 5 (22.73%) | 4 (33.33%) | |
| Lesser curvature | 9 (26.5%) | 7 (31.81%) | 2 (16.67%) | |
| Greater curvature | 14 (41.2%) | 9 (40.91%) | 5 (41.67%) | |
| Antrum | 2 (5.9%) | 1 (4.55%) | 1 (8.33%) | |
| Operation time (min; mean ± SD) | 152.5 ± 56.034 | 150.91 ± 59.435 | 155.42 ± 51.587 | 0.827 |
| EBL (ml; mean ± SD) | 151.47 ± 60.309 | 157.27 ± 61.581 | 140.83 ± 59.001 | 0.456 |
| Blood transfusion | 1 (2.9%) | 1 (4.55%) | 0 (0%) | 0.453 |
| Operative complications | 0 (0%) | 0 (0%) | 0 (0%) | |
| Intraoperative tumor rupture | 0 (0%) | 0 (0%) | 0 (0%) | |
| POP complications (CD classification) | 0.909 | |||
| CD I | 30 (88.2%) | 19 (86.36%) | 11(91.67%) | |
| CD II | 3 (8.8%) | 2 (9.09%) | 1 (8.33%) | |
| Ambulation (days; mean ± SD) | 1 ± 0.83 | 1.50 ± 0.512 | 0.00 ± 0.00 | < 0.005 |
| Oral intake (days; mean ± SD) | 2.21 ± 1.30 | 2.95 ± 0.999 | 0.83 ± 0.389 | < 0.005 |
| ICU stay (days; mean ± SD) | 0.03 ± 0.171 | 0.05 ± 0.213 | 0.00 ± 0.00 | 0.469 |
| Hospital stay (days; mean ± SD) | 5 ± 1.97 | 6.05 ± 1.588 | 3.08 ± 0.793 | < 0.005 |
| 30-day mortality | 1 (2.9%) | 1 (4.55%) | 0 (0%) | 0.453 |
EBL estimated blood loss, POP postoperative, CD Clavien Dindo